We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Headache Frequent After Acoustic Neuroma Surgery

By HospiMedica staff writers
Posted on 19 Nov 2007
A new study has found that headache is twice as common after acoustic neuroma surgery than before, and the new onset headache appears to typically have certain common characteristics.

Researchers at the University of Helsinki (Finland) examined survey responses from 192 patients who had undergone acoustic neuroma surgery. More...
In all, 61 (32%) reported headache preoperatively, of which 47 patients reported migraine and nine did so for tension-type headache. After the operation, 122 patients (64%) reported headache. This included 15 respondents with new migraine and four with new tension-type headache. In 86% of the patients, the postoperative headache was chronic, lasting at least three months. At the time of the survey, the headache persisted in 55%, and typically presented in severe short attacks, provoked by physical stress, bending, or coughing. Treatment with non-steroidal anti-inflammatory drugs was usually effective. The study was published in the October 2007 issue of Cephalalgia.

"Headache after acoustic neuroma operation is relatively common, and variations in neurosurgical techniques have not solved the problem completely,” said lead author Dr. Tuomas Rimaaja, D.D.S. "Surgical treatment of acoustic neuroma means major skull base surgery to patients experiencing only minimal preoperative symptoms, and may lead to major postoperative symptoms. Patients need to be well informed about possible outcomes after surgery.”

An acoustic neuroma is a benign primary intracranial tumor of the myelin-forming cells of the vestibulocochlear (VIII) nerve. The correct medical term is actually vestibular schwannoma, since it involves the vestibular portion of the 8th cranial nerve and it arises from Schwann cells, which are responsible for the myelin sheath in the peripheral nervous system. The prevalence of the neuroma is 1:100,000 worldwide. Incidence peaks in the fifth and sixth decades and both sexes are affected equally.


Related Links:
University of Helsinki

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.